Clinical presentation and genetic analyses of neurofibromatosis type 1 in independent patients with monoallelic double de novo closely spaced mutations in the NF1 gene

Hum Mutat. 2022 Oct;43(10):1354-1360. doi: 10.1002/humu.24423. Epub 2022 Jun 28.

Abstract

Neurofibromatosis type 1 (NF1) belongs to RASopathies, a group of syndromes caused by germline mutations in Ras/MAPK pathway genes. Most NF1 patients exhibit single inactivating pathogenic variants within the NF1 gene. We performed extensive genetic analyses in two NF1 families disclosing the first two cases of double de novo monoallelic NF1 variants. Both index patients described in this study had classical NF1. Probands were born from fathers in their late 30s and presented closely spaced double mutations (<100 bp) in NF1 regions showing an excess of somatic mutations. Closely spaced multiple mutations have been reported in RAS/MAPK signaling genes but never in NF1. Mutagenesis is a quasi-random process in humans, therefore two causative variants in the same gene, moreover in the same allele are exceptional. Here, we discuss possible mechanisms for this ultrarare event. Our findings confirm the possibility of a higher risk of concurrent de novo variants in NF1.

Keywords: closely spaced multiple mutations; de novo mutations; in cis doublets; neurofibromatosis type 1; paternal age effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genes, Neurofibromatosis 1
  • Genetic Testing
  • Germ-Line Mutation
  • Humans
  • Mutation
  • Neurofibromatosis 1* / diagnosis
  • Neurofibromatosis 1* / genetics